These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 19196965

  • 1. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia.
    Alonso-Magdalena P, Brössner C, Reiner A, Cheng G, Sugiyama N, Warner M, Gustafsson JA.
    Proc Natl Acad Sci U S A; 2009 Feb 24; 106(8):2859-63. PubMed ID: 19196965
    [Abstract] [Full Text] [Related]

  • 2. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
    Shao R, Shi J, Liu H, Shi X, Du X, Klocker H, Lee C, Zhu Y, Zhang J.
    Prostate; 2014 Jun 24; 74(9):970-82. PubMed ID: 24752964
    [Abstract] [Full Text] [Related]

  • 3. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM, Sehgal PD, Drew SA, Huang W, Ricke WA.
    Differentiation; 2013 Jun 24; 85(4-5):140-9. PubMed ID: 23792768
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M, De Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile B, Paniagua R.
    Growth Factors; 1998 Jun 24; 16(2):101-10. PubMed ID: 9932228
    [Abstract] [Full Text] [Related]

  • 5. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
    Hu S, Yu W, Lv TJ, Chang CS, Li X, Jin J.
    Mol Membr Biol; 2014 Jun 24; 31(2-3):103-10. PubMed ID: 24650126
    [Abstract] [Full Text] [Related]

  • 6. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
    Lu T, Lin WJ, Izumi K, Wang X, Xu D, Fang LY, Li L, Jiang Q, Jin J, Chang C.
    Mol Endocrinol; 2012 Oct 24; 26(10):1707-15. PubMed ID: 22915828
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase.
    Miao L, Jiao C, Shao R, Qi Y, Fan G, Li X, Wang Y, Zhu Y, Zhang J, Gao X.
    Toxicol Appl Pharmacol; 2019 Oct 15; 381():114637. PubMed ID: 31238046
    [Abstract] [Full Text] [Related]

  • 10. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway.
    Liu D, Liu J, Li Y, Liu H, Hassan HM, He W, Li M, Zhou Y, Fu X, Zhan J, Wang Z, Yang S, Chen P, Xu D, Wang X, DiSanto ME, Zeng G, Zhang X.
    Prostate; 2021 Dec 15; 81(16):1435-1449. PubMed ID: 34553788
    [Abstract] [Full Text] [Related]

  • 11. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway.
    Kim HJ, Jin BR, An HJ.
    Biomed Pharmacother; 2023 Apr 15; 160():114389. PubMed ID: 36791565
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR, Petrangeli E, Salvatori L, Ravenna L, Di Silverio F.
    Anal Quant Cytol Histol; 2000 Oct 15; 22(5):403-10. PubMed ID: 11064817
    [Abstract] [Full Text] [Related]

  • 14. MIR663AHG as a competitive endogenous RNA regulating TGF-β-induced epithelial proliferation and epithelial-mesenchymal transition in benign prostate hyperplasia.
    Tong S, Mo M, Hu X, Wu L, Chen M, Zhao C.
    J Biochem Mol Toxicol; 2023 Sep 15; 37(9):e23391. PubMed ID: 37518988
    [Abstract] [Full Text] [Related]

  • 15. Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.
    Wang L, Xie L, Tintani F, Xie H, Li C, Cui Z, Wan M, Zu X, Qi L, Cao X.
    Stem Cells Transl Med; 2017 Feb 15; 6(2):394-404. PubMed ID: 28191756
    [Abstract] [Full Text] [Related]

  • 16. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.
    McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH, Risbridger GP.
    Endocrinology; 2007 Feb 15; 148(2):566-74. PubMed ID: 17068134
    [Abstract] [Full Text] [Related]

  • 17. Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells.
    Wang K, Pascal LE, Li F, Chen W, Dhir R, Balasubramani GK, DeFranco DB, Yoshimura N, He D, Wang Z.
    Prostate; 2020 Oct 15; 80(14):1203-1215. PubMed ID: 32692865
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta expression in prostate neoplasia.
    Cardillo MR, Petrangeli E, Perracchio L, Salvatori L, Ravenna L, Di Silverio F.
    Anal Quant Cytol Histol; 2000 Feb 15; 22(1):1-10. PubMed ID: 10696454
    [Abstract] [Full Text] [Related]

  • 19. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features.
    Gabal SM, Habib FM, Helmy DO, Ibrahim MF.
    J Egypt Natl Canc Inst; 2007 Dec 15; 19(4):239-48. PubMed ID: 19672287
    [Abstract] [Full Text] [Related]

  • 20. LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia.
    He Y, Ou Z, Chen X, Zu X, Liu L, Li Y, Cao Z, Chen M, Chen Z, Chen H, Qi L, Wang L.
    Sci Rep; 2016 May 31; 6():27051. PubMed ID: 27243216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.